All change in Germany – confidential pricing in, IRP out
On 1 January 2025, important legal amendments relating to drug pricing in Germany that were included in the Medical Research…
Pricing and Market Access
JP Morgan 2025: Almirall updates strategy with focus on medical dermatology
Pharma to raise prices on more than 250 drugs in the US from January 2025
Setback for UK pharma as government sets unexpectedly high VPAG payback rate in 2025
Denmark’s HTA evolution
Navigating medicine pricing in Turkiye: the pharmaceutical Euro exchange rate
South Korean pricing reform suggests more flexible drug reimbursement negotiations
Keytruda and Opdivo: a decade review
